Novartis names Mehta new CFO

After 22 years at Swiss pharma Novartis AG (SIX:NOVN; NYSE:NVS), CFO Harry Kirsch plans to retire on March 15, 2026. He will be replaced by Mukul Mehta, Novartis’ head of business planning and analysis for digital finance and tax. Kirsch was CFO during Novartis’ transition from pharmaceutical conglomerate into a pure-play biopharma company, which, on Thursday, reported 11% net sales growth in its 2Q25 earnings.

Biontech SE (NASDAQ:BNTX) also announced a departure from its leadership team, with Chief Strategy Officer Ryan Richardson stepping down, effective Sept. 30. The company said decision was made by mutual agreement as Richardson plans to pursue other professional opportunities. ...